The tables below cover injectable protocols from 1mg to 3mg daily, topical applications from 0.5% to 4% concentration, and reconstitution calculations for both 50mg and 100mg vials
That is intentional: the two vial sizes reflect two different documented protocols and two different concentration setups, and it is a reminder never to eyeball a dose across vial sizes
This is why medical screening before use matters
No placebo-controlled human trial was identified for weight management, diabetes, fatty liver disease, sarcopenia, athletic performance or healthy ageing
For instance, patients may experience symptoms related to liver disease (such as jaundice, abdominal swelling, or fatigue), haematological disorders (including unexplained bruising, night sweats, or weight loss), or kidney dysfunction (such as reduced urine output or swelling)
However, simply requesting an injection a day early is unlikely to meet this threshold